Nymox Pharmaceutical
NYMX
#10189
Rank
A$27.47 M
Marketcap
Country
A$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Net assets

Net assets on the balance sheet as of June 2023 : -A$4.34 Million

According to Nymox Pharmaceutical's latest financial reports the company has -A$4.34 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nymox Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$-A$0.71 Million1.48%
2021-12-31$-A$0.7 Million-125.02%
2020-12-31$A$2.78 M-43.36%
2019-12-31$A$4.92 M-50.45%
2018-12-31$A$9.93 M-720.28%
2017-12-31$-A$1.61 Million80.08%
2016-12-31$-A$0.89 Million-76.45%
2015-12-31$-A$3.78 Million-26.03%
2014-12-31$-A$5.11 Million-24.78%
2013-12-31$-A$6.8 Million-5.19%
2012-12-31$-A$7.17 Million41.33%
2011-12-31$-A$5.07 Million80.38%
2010-12-31$-A$2.82 Million73.84%
2009-12-31$-A$1.62 Million-140.58%
2008-12-31$A$3.98 M17.45%
2007-12-31$A$3.39 M46.4%
2006-12-31$A$2.31 M39.87%
2005-12-31$A$1.65 M-36.3%
2004-12-31$A$2.6 M-19.41%
2003-12-31$A$3.22 M-37.03%
2002-12-31$A$5.12 M-24.08%
2001-12-31$A$6.74 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Abbott Laboratories
ABT
A$77.17 B-1,781,956.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B-3,235,970.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$11.10 B-256,478.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.90 B-829,116.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B-2,755,643.97%๐Ÿ‡บ๐Ÿ‡ธ USA